116 related articles for article (PubMed ID: 37944631)
1. Unexpected extra exon skipping in the DYSF gene during restoring the reading frame by CRISPR/Cas9.
Levchenko O; Panchuk I; Kochergin-Nikitsky K; Petrova I; Nagieva S; Pilkin M; Yakovlev I; Smirnikhina S; Deev R; Lavrov A
Biosystems; 2024 Jan; 235():105072. PubMed ID: 37944631
[TBL] [Abstract][Full Text] [Related]
2. Restoration of Dystrophin Protein Expression by Exon Skipping Utilizing CRISPR-Cas9 in Myoblasts Derived from DMD Patient iPS Cells.
Ifuku M; Iwabuchi KA; Tanaka M; Lung MSY; Hotta A
Methods Mol Biol; 2018; 1828():191-217. PubMed ID: 30171543
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion.
Mou H; Smith JL; Peng L; Yin H; Moore J; Zhang XO; Song CQ; Sheel A; Wu Q; Ozata DM; Li Y; Anderson DG; Emerson CP; Sontheimer EJ; Moore MJ; Weng Z; Xue W
Genome Biol; 2017 Jun; 18(1):108. PubMed ID: 28615073
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9 gene editing causes alternative splicing of the targeting mRNA.
Zhang Q; Fu Y; Thakur C; Bi Z; Wadgaonkar P; Qiu Y; Xu L; Rice M; Zhang W; Almutairy B; Chen F
Biochem Biophys Res Commun; 2020 Jul; 528(1):54-61. PubMed ID: 32460957
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic exon skipping for dysferlinopathies?
Aartsma-Rus A; Singh KH; Fokkema IF; Ginjaar IB; van Ommen GJ; den Dunnen JT; van der Maarel SM
Eur J Hum Genet; 2010 Aug; 18(8):889-94. PubMed ID: 20145676
[TBL] [Abstract][Full Text] [Related]
6. Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein.
Kagita A; Lung MSY; Xu H; Kita Y; Sasakawa N; Iguchi T; Ono M; Wang XH; Gee P; Hotta A
Stem Cell Reports; 2021 Apr; 16(4):985-996. PubMed ID: 33711268
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-mediated genome editing induces exon skipping by complete or stochastic altering splicing in the migratory locust.
Chen D; Tang JX; Li B; Hou L; Wang X; Kang L
BMC Biotechnol; 2018 Sep; 18(1):60. PubMed ID: 30253761
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human
Egorova TV; Zotova ED; Reshetov DA; Polikarpova AV; Vassilieva SG; Vlodavets DV; Gavrilov AA; Ulianov SV; Buchman VL; Deykin AV
Dis Model Mech; 2019 Apr; 12(4):. PubMed ID: 31028078
[TBL] [Abstract][Full Text] [Related]
9. Machine learning based CRISPR gRNA design for therapeutic exon skipping.
Louie W; Shen MW; Tahiry Z; Zhang S; Worstell D; Cassa CA; Sherwood RI; Gifford DK
PLoS Comput Biol; 2021 Jan; 17(1):e1008605. PubMed ID: 33417623
[TBL] [Abstract][Full Text] [Related]
10. Dysferlin Exon 32 Skipping in Patient Cells.
Barthélémy F; Courrier S; Lévy N; Krahn M; Bartoli M
Methods Mol Biol; 2018; 1828():489-496. PubMed ID: 30171562
[TBL] [Abstract][Full Text] [Related]
11. Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping.
Gee P; Lung MSY; Okuzaki Y; Sasakawa N; Iguchi T; Makita Y; Hozumi H; Miura Y; Yang LF; Iwasaki M; Wang XH; Waller MA; Shirai N; Abe YO; Fujita Y; Watanabe K; Kagita A; Iwabuchi KA; Yasuda M; Xu H; Noda T; Komano J; Sakurai H; Inukai N; Hotta A
Nat Commun; 2020 Mar; 11(1):1334. PubMed ID: 32170079
[TBL] [Abstract][Full Text] [Related]
12. Adenine base-editing-mediated exon skipping induces gene knockout in cultured pig cells.
Zhu XX; Pan JS; Lin T; Yang YC; Huang QY; Yang SP; Qu ZX; Lin ZS; Wen JC; Yan AF; Feng J; Liu L; Zhang XL; Lu JH; Tang DS
Biotechnol Lett; 2022 Jan; 44(1):59-76. PubMed ID: 34997407
[TBL] [Abstract][Full Text] [Related]
13. Morpholino-Mediated Exons 28-29 Skipping of Dysferlin and Characterization of Multiexon-skipped Dysferlin using RT-PCR, Immunoblotting, and Membrane Wounding Assay.
Anwar S; Yokota T
Methods Mol Biol; 2023; 2587():183-196. PubMed ID: 36401031
[TBL] [Abstract][Full Text] [Related]
14. Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy.
Lee JJA; Maruyama R; Duddy W; Sakurai H; Yokota T
Mol Ther Nucleic Acids; 2018 Dec; 13():596-604. PubMed ID: 30439648
[TBL] [Abstract][Full Text] [Related]
15. Antisense-Mediated Skipping of Dysferlin Exons in Control and Dysferlinopathy Patient-Derived Cells.
Verwey N; Gazzoli I; Krause S; Mamchaoui K; Mouly V; Aartsma-Rus A
Nucleic Acid Ther; 2020 Apr; 30(2):71-79. PubMed ID: 31873062
[TBL] [Abstract][Full Text] [Related]
16. Genome editing through large insertion leads to the skipping of targeted exon.
Uddin B; Chen NP; Panic M; Schiebel E
BMC Genomics; 2015 Dec; 16():1082. PubMed ID: 26691863
[TBL] [Abstract][Full Text] [Related]
17. Efficient bypass of mutations in dysferlin deficient patient cells by antisense-induced exon skipping.
Wein N; Avril A; Bartoli M; Beley C; Chaouch S; Laforêt P; Behin A; Butler-Browne G; Mouly V; Krahn M; Garcia L; Lévy N
Hum Mutat; 2010 Feb; 31(2):136-42. PubMed ID: 19953532
[TBL] [Abstract][Full Text] [Related]
18. Preparation of NanoMEDIC Extracellular Vesicles to Deliver CRISPR-Cas9 Ribonucleoproteins for Genomic Exon Skipping.
Watanabe K; Gee P; Hotta A
Methods Mol Biol; 2023; 2587():427-453. PubMed ID: 36401042
[TBL] [Abstract][Full Text] [Related]
19. Construction of an Inducible CRISPR/Cas9 System for CXCR4 Gene and Demonstration of its Effects on MKN-45 Cells.
Peng Y; Yang T; Tang X; Chen F; Wang S
Cell Biochem Biophys; 2020 Mar; 78(1):23-30. PubMed ID: 31875277
[TBL] [Abstract][Full Text] [Related]
20. Unexpected consequences: exon skipping caused by CRISPR-generated mutations.
Sharpe JJ; Cooper TA
Genome Biol; 2017 Jun; 18(1):109. PubMed ID: 28615035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
